# Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft

> **NCT02218515** · PHASE4 · COMPLETED · sponsor: **Haner Direskeneli, Prof** · enrollment: 30 (actual)

## Conditions studied

- Periodontal Bone Loss
- Chronic Periodontitis

## Interventions

- **PROCEDURE:** Open Flap Debridement
- **BIOLOGICAL:** EmdogainⓇ(Enamel Matrix Derivative)
- **BIOLOGICAL:** EmdogainⓇEnamel Matrix Derivative+Autogenous Bone

## Key facts

- **NCT ID:** NCT02218515
- **Lead sponsor:** Haner Direskeneli, Prof
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02218515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02218515, "Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02218515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*